Responses
Clinical/translational cancer immunotherapy
Original research
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.